Pharma
The EU Council and European Parliament have agreed on a new “Pharma Package” – a major update to medicines rules in Europe. This is one […]
Read morePharma
Pharmaceutical innovator companies increasingly have to consider the potential prior art effect of clinical studies carried out in order to gain approval of their medicines. […]
Read morePharma
In 2020, the number of international patent applications filed via WIPO continued to grow amid the COVID-19 pandemic, and within the field of technology, medical […]
Read morePharma
ALL the applicants of a priority application must be named in a subsequent EP application As discussed in a previous post, there were oral proceedings […]
Read morePharma
Patenting of a second (or further) medical use of an already known pharmaceutically active ingredient has been possible at the EPO since decision G 5/83. […]
Read morePharma
Tuesday this week, it was revealed that Gilead, the producer of Remdesivir, which is currently known as the best drug against COVID-19, had sold nearly […]
Read more